Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshinao Tanahashi is active.

Publication


Featured researches published by Yoshinao Tanahashi.


Journal of Hepato-biliary-pancreatic Sciences | 2015

Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: A multi-institutional Japanese study

Takeshi Takahara; Go Wakabayashi; Toru Beppu; Arihiro Aihara; Kiyoshi Hasegawa; Naoto Gotohda; Etsuro Hatano; Yoshinao Tanahashi; Toru Mizuguchi; Toshiya Kamiyama; Tetsuo Ikeda; Shogo Tanaka; Nobuhiko Taniai; Hideo Baba; Minoru Tanabe; Norihiro Kokudo; Masaru Konishi; Shinji Uemoto; Atsushi Sugioka; Koichi Hirata; Akinobu Taketomi; Yoshihiko Maehara; Shoji Kubo; Eiji Uchida; Hiroaki Miyata; Masafumi Nakamura; Hironori Kaneko; Hiroki Yamaue; Masaru Miyazaki; Tadahiro Takada

The aim of this study was to compare the long‐term outcomes and perioperative outcomes of laparoscopic liver resection (LLR) with those of open liver resection (OLR) for hepatocellular carcinoma (HCC) between well‐matched patient groups.


World Journal of Hepatology | 2010

Surgery and chemotherapy for intrahepatic cholangiocarcinoma.

Zenichi Morise; Atsushi Sugioka; Takamasa Tokoro; Yoshinao Tanahashi; Yasuhiro Okabe; Tadashi Kagawa; Chinatsu Takeura

Cholangiocarcinoma, arising from bile duct epithelium, is categorized into intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC), including hilarcholangiocarcinoma. Recently, there has been a worldwide increase in the incidence and mortality from ICC. Complete surgical resection is the only approach to cure the patients with ICC. However, locoregional extension of these tumors is usually advanced with intrahepatic and lymph-node metastases at the time of diagnosis. Resectability rates are quite low and variable (18%-70%). The five-year survival rate after surgical resection was reported to be 20%-40%. Median survival time after ICC resection was 12-37.4 mo. Only a small number of ICC cases, accompanied with ECC, gall bladder carcinoma, and ampullary carcinoma, have been reported in the studies of chemotherapy due to the rarity of the disease. However, in some reports, significant anti-cancer effects were achieved with a response rate of up to 40% and a median survival of one year. Although recurrence rate after hepatectomy is high for the patients with ICC, the residual liver and the lung are the main sites of recurrence after tentative curative surgical resection. Several patients in our study had a long-term survival with repeated surgery and chemotherapy. Repeated surgery, combined with new effective regimens of chemotherapy, could benefit the survival of ICC patients.


Rare Tumors | 2009

Plexiform neurofibroma in the hepatic hilum associated with neurofibromatosis type 1: a case report

Sojun Hoshimoto; Zenichi Morise; Chinatsu Takeura; Masahiro Ikeda; Tadashi Kagawa; Yoshinao Tanahashi; Yasuhiro Okabe; Yoshikazu Mizoguchi; Atsushi Sugioka

We present an extremely rare case of plexiform neurofibroma involving the hepatic hilum. A 24-year old woman who had been diagnosed with neurofibromatosis type 1 was referred to our hospital for evaluation of an abdominal mass found on computed tomography and progressive aggravation of intermittent abdominal pain. Abdominal computed tomography revealed a multilobulated non-enhancing mass involving the celiac trunk and hepatic artery, that extended to the hepatic hilum through the hepatoduodenal ligament. Magnetic resonance imaging showed the lesion extending along the intrahepatic Glissons sheath. Based on the imaging findings, the patient was diagnosed to have a neu-rofibroma, although sarcomatous differentiation could not be excluded. The tumor was resected, leaving behind the intrahepatic extension, with the aim of alleviating the abdominal pain and preventing obstructive jaundice. Histopathological examination revealed the diagnosis of plexiform neurofibroma. At present, three years after the surgery, the patient remains symptom-free, without any evidence of recurrence.


Journal of Hepato-biliary-pancreatic Surgery | 2008

Patient with advanced intrahepatic cholangiocarcinoma with long-term survival successfully treated with a combination of surgery and chemotherapy

Zenichi Morise; Atsushi Sugioka; Sojun Hoshimoto; Takazumi Kato; Yoshinao Tanahashi; Masahiro Ikeda; Tadashi Kagawa

Intrahepatic cholangiocarcinoma (ICC) is a relatively rare malignancy arising from the biliary epithelium. Prognosis is typically poor. Currently, aggressive surgical resection is the only treatment modality that offers patients any chance of long-term survival. Here, we present the case of a 57-year-old woman in whom we diagnosed ICC, with the tumor occupying the entire left and caudate hepatic lobes and daughter nodules in the right lobe. She underwent hepatectomy of segments I to VI, combined with intraoperative microwave coagulation therapy for nodules in the residual liver. Three months after the surgical resection, she had recurrence of the disease. The patient subsequently received weekly intraarterial chemotherapy with irinotecan (CPT-11), and a partial response was observed which persisted for 18 months. Subsequent computed tomography revealed the regrowth of three tumors, and she therefore underwent a repeat resection 24 months after the first surgical operation. In postoperative-month (POM) 32, she received systemic chemotherapy with tegatur/gimeracil/oteracil potassium (S-1)/cisplatin for multiple small nodules in her lung. Following three cycles of chemotherapy with a stable disease response, partial resections of the lung were performed. Third and fourth hepatectomies were performed in POMs 46 and 59, respectively. Five years and 5 months after the first hepatectomy, she is alive with small lesions in her lung. This multimodal approach may be effective for ICC.


Rare Tumors | 2009

Malignant Triton tumor in the retroperitoneal space associated with neurofibromatosis type 1: a case study

Sojun Hoshimoto; Zenichi Morise; Chinatsu Takeura; Masahiro Ikeda; Tadashi Kagawa; Yoshinao Tanahashi; Yasuhiro Okabe; Yoshikazu Mizoguchi; Atsushi Sugioka

We report an extremely rare case of malignant Triton tumor developing in the retroperitoneal space in a patient with neurofibromatosis type 1. A 21-year old man who had been diagnosed with neurofibromatosis type 1 was admitted to our hospital with the chief complaint of a palpable abdominal mass. Abdominal computed tomography revealed a huge heterogeneous tumor measuring approximately 17 cm in diameter occupying the left retroperitoneal space, and numerous metastatic lesions between the left psoas muscle and the left thigh with dissolution of the left hip joint. After the diagnosis of a retroperitoneal malignant neurogenic tumor, resection of the tumor with reconstruction of the abdominal aorta was conducted, followed by postoperative transarterial infusion chemotherapy. The histopathological diagnosis was malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation, namely malignant Triton tumor. Postoperative chemotherapy was in vain and the patient died 14 months after the surgery as a result of lung metastasis.


Journal of Hepato-biliary-pancreatic Sciences | 2017

Systematic extrahepatic Glissonean pedicle isolation for anatomical liver resection based on Laennec's capsule: proposal of a novel comprehensive surgical anatomy of the liver

Atsushi Sugioka; Y. Kato; Yoshinao Tanahashi

Anatomical liver resection with the Glissonean pedicle isolation is widely approved as an essential procedure for safety and curability. Especially, the extrahepatic Glissonean pedicle isolation without parenchymal destruction should be an ideal procedure. However, the surgical technique has not been standardized due to a lack of anatomical understanding. Herein, we proposed a novel comprehensive surgical anatomy of the liver based on Laennecs capsule that would give a theoretical background to the extrahepatic Glissonean pedicle isolation. Laennecs capsule is the proper membrane that covers not only the entire surface of the liver including the bare area but also the intrahepatic parenchyma surrounding the Glissonean pedicles. Consequently, there exists a gap between the Glissonean pedicle and Laennecs capsule that could be reached extrahepatically and allows us to isolate the extrahepatic Glissonean pedicle without parenchymal destruction systematically. For standardization, it is essential to approach the “six gates” indicated by the “four anatomical landmarks”: the Arantius plate, the umbilical plate, the cystic plate and the Glissonean pedicle of the caudate process (G1c). This novel anatomy would contribute to standardize the surgical techniques of the systematic extrahepatic Glissonean pedicle isolation for anatomical liver resection including laparoscopic or robotic liver resection and to bring innovative changes in hepatobiliary surgery for spreading safe and curable liver resection.


Pediatric Transplantation | 2016

Successful living donor liver transplantation for classical maple syrup urine disease

Toshihiro Yasui; Tatsuya Suzuki; Fujio Hara; Shunsuke Watanabe; Naoko Uga; Atsuki Naoe; Tetsushi Yoshikawa; Tetsuya Ito; Yoko Nakajima; Hiroki Miura; Atsushi Sugioka; Y. Kato; Takamasa Tokoro; Yoshinao Tanahashi; Mureo Kasahara; Akinari Fukuda; Hiroki Kurahashi

MSUD is an autosomal recessive condition characterized by a deficiency in the enzyme, BCKDH, which catalyzes the breakdown of BCAAs. If left untreated, MSUD can result in mental retardation, central nervous system disorders, and even death. Most patients with MSUD are treated with a restricted protein diet and milk from which BCAAs have been removed. LT has been shown effective in patients with MSUD. This report describes the case of a 15‐month‐old boy who received a liver graft from his mother. Transplantation was successful, and the patient was then able to ingest a normal diet. Despite episodes of acute rejection, chylous ascites, and high fever (40 °C), he has shown no evidence of MSUD recurrence. These findings indicate that patients with MSUD can be successfully treated by LDLT, even when the donor is a heterozygous carrier of a mutated BCKDH gene.


Gastroenterology | 2009

W1493 Surgical Treatment for the Patients of Intrahepatic Cholangiocarcinoma with Lymph Node Metastases – Repeat Surgery and Combined Chemotherapy for Recurrence

Zenichi Morise; Atsushi Sugioka; Yoshinao Tanahashi; Yasuhiro Okabe

major resection was 188 and 251 mins for minor. There was one postoperative mortality due to respiratory failure. Bile leak needing stenting occurred in 1 patient. Median blood loss for major resection was 500 ml and 265 ml for minor. Intraoperative transfusion was required in 9 major and 1 minor resections. Other complications were ileus in 4, DVT in 2, intrabdominal abscess in 1 and cardiac events in 2 patients. Conclusion: Liver precoagulation with MW technology is a novel and efficient technique with minimal morbidity and mortality for liver transection.


Journal of Hepato-biliary-pancreatic Surgery | 2009

Hepatocellular carcinoma with extensive peliotic change

Sojun Hoshimoto; Zenichi Morise; Keiichi Suzuki; Yoshinao Tanahashi; Masahiro Ikeda; Tadashi Kagawa; Yoshizumi Mizoguchi; Atsushi Sugioka


Case Reports in Gastroenterology | 2011

Hepatic Sarcoidosis Mimicking Hilar Cholangiocarcinoma: Case Report and Review of the Literature

Keiichi Suzuki; Zenichi Morise; Shinpei Furuta; Yoshinao Tanahashi; Chinatsu Takeura; Tadashi Kagawa; Masahiro Ikeda; Atsushi Sugioka

Collaboration


Dive into the Yoshinao Tanahashi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tadashi Kagawa

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar

Zenichi Morise

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masahiro Ikeda

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar

Y. Kato

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar

Yasuhiro Okabe

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Tsuji

Fujita Health University

View shared research outputs
Researchain Logo
Decentralizing Knowledge